CompanyMTNBNYSEBedminster, NJ

Matinas BioPharma Holdings, Inc.

Matinas BioPharma develops therapies using lipid nanocrystal platform technology for drug delivery.

SEC EDGAR ClinicalTrials.gov matinasbiopharma.com

DEF 14ASep 28Latest SEC filing

Jul 24Latest story

July 2026

Matinas BioPharma's at-the-market sales pact with BTIG terminated

Jul 24PartnershipMatinas BioPharma Holdings, Inc.

Matinas to combine with GH Power, sell drug unit MAT2203 to Azurity

Jul 13PartnershipMatinas BioPharma Holdings, Inc.